FiercePharma

BioNTech to wind down cell therapy manufacturing in Maryland, lay off 63 as it ends development of CAR-T drug in testicular cancer

Following a disappointing performance from the company’s CAR-T candidate in an early-stage cancer trial, BioNTech is winding down cell therapy manufacturing at its inaugural U.S. plant. BioNTech will ...
MarketBeat on MSN

BioNTech maps oncology push, $1B buyback and manufacturing cuts at AGM

4 Reasons Pfizer Could Be a Value Play You Can't Miss BioNTech (NASDAQ:BNTX) used its virtual annual general meeting to outline a transition year marked by leadership changes, continued investment in ...
JD Supra

GSK Sues Pfizer, Pharmacia & Upjohn & BioNTech for Infringing mRNA Vaccine Patents

Late last week, GlaxoSmithKline Biologicals SA and GlaxoSmithKline LLC filed suit in the District of Delaware alleging that Pfizer, Pharmacia & Upjohn, BioNtech SE, BioNtech Manufacturing GMBH, and ...
Seeking Alpha

CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2025 and Provides Business Updates

German Federal Cartel Office clearance obtained for the planned BioNTech - CureVac transaction announced on June 12, 2025, marking an important step toward the expected closing later this year Offer ...
FierceBiotech

BioNTech pays Autolus $250M for manufacturing, CAR-T expertise in wide-ranging collab

BioNTech has already been tinkering with its manufacturing processes in the run up to CAR-T BNT211 entering pivotal trials. Now, the German biotech has brought British company Autolus Therapeutics on ...
OnVista

Biontech schließt deutsche Werke und streicht 1860 Stellen

Nur wenige Wochen nach dem angekündigten Rückzug des Gründer-Ehepaars zieht Biontech einen radikalen Schlussstrich unter die Corona-Ära: Das Mainzer Biotechunternehmen stellt seine ...
Nasdaq

BioNTech Expands Global Footprint by Acquiring GMP Manufacturing Site to Establish First mRNA Facility in Singapore

MAINZ, GERMANY, and SINGAPORE, November 14, 2022 — BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) today announced its Singapore affiliate BioNTech Pharmaceuticals Asia Pacific Pte. Ltd. had ...
FiercePharma

BioNTech to slash 1,860 jobs, exit sites in Germany and Singapore in major manufacturing pullback

In an effort to reallocate resources to its growing oncology focus in the face of shrinking COVID-19 vaccine sales, German company BioNTech is slashing a large chunk of its manufacturing footprint, ...
Business Insider

BioNTech Announces First Quarter 2026 Financial Results and Corporate Update

Conference call and webcast scheduled for May 5, 2026, at 8:00 a.m. ET (2:00 p.m. CET) MAINZ, Germany, May 5, 2026 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) today ...
Seeking Alpha

BioNTech Strengthens Manufacturing Capabilities with First In-House Plasmid DNA Manufacturing Facility

MAINZ, Germany, February 2, 2023 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) today announced construction completion of the Company’s first proprietary plasmid DNA manufacturing facility ...
GEN

BioNTech Acquires mRNA Manufacturing Facility in Singapore

BioNTech reports that its Singapore affiliate, BioNTech Pharmaceuticals Asia Pacific, signed an agreement Novartis Singapore Pharmaceutical Manufacturing to acquire one of its GMP-certified ...